Cargando…
KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
BACKGROUND: There remains a need to identify and validate biomarkers for predicting prostate cancer (CaP) outcomes using robust and routinely available pathology techniques to identify men at most risk of premature death due to prostate cancer. Previous immunohistochemical studies suggest the prolif...
Autores principales: | Green, William JF, Ball, Graham, Hulman, Geoffrey, Johnson, Catherine, Van Schalwyk, Gerry, Ratan, Hari L, Soria, Daniel, Garibaldi, Jonathan M, Parkinson, Richard, Hulman, Joshua, Rees, Robert, Powe, Desmond G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947696/ https://www.ncbi.nlm.nih.gov/pubmed/27336609 http://dx.doi.org/10.1038/bjc.2016.169 |
Ejemplares similares
-
Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
por: Wangsa, D, et al.
Publicado: (2008) -
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012) -
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013) -
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013) -
The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma
por: Klimowicz, A C, et al.
Publicado: (2013)